126 related articles for article (PubMed ID: 11597899)
1. Dose-dependent lung remodeling in transgenic mice expressing transforming growth factor-alpha.
Hardie WD; Piljan-Gentle A; Dunlavy MR; Ikegami M; Korfhagen TR
Am J Physiol Lung Cell Mol Physiol; 2001 Nov; 281(5):L1088-94. PubMed ID: 11597899
[TBL] [Abstract][Full Text] [Related]
2. Dose-related protection from nickel-induced lung injury in transgenic mice expressing human transforming growth factor-alpha.
Hardie WD; Prows DR; Piljan-Gentle A; Dunlavy MR; Wesselkamper SC; Leikauf GD; Korfhagen TR
Am J Respir Cell Mol Biol; 2002 Apr; 26(4):430-7. PubMed ID: 11919079
[TBL] [Abstract][Full Text] [Related]
3. Postnatal lung function and morphology in transgenic mice expressing transforming growth factor-alpha.
Hardie WD; Bruno MD; Huelsman KM; Iwamoto HS; Carrigan PE; Leikauf GD; Whitsett JA; Korfhagen TR
Am J Pathol; 1997 Oct; 151(4):1075-83. PubMed ID: 9327741
[TBL] [Abstract][Full Text] [Related]
4. Conditional expression of transforming growth factor-alpha in adult mouse lung causes pulmonary fibrosis.
Hardie WD; Le Cras TD; Jiang K; Tichelaar JW; Azhar M; Korfhagen TR
Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L741-9. PubMed ID: 14660483
[TBL] [Abstract][Full Text] [Related]
5. Reversal of lung lesions in transgenic transforming growth factor alpha mice by expression of mutant epidermal growth factor receptor.
Hardie WD; Kerlakian CB; Bruno MD; Huelsman KM; Wert SE; Glasser SW; Whitsett JA; Korfhagen TR
Am J Respir Cell Mol Biol; 1996 Oct; 15(4):499-508. PubMed ID: 8879184
[TBL] [Abstract][Full Text] [Related]
6. Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice.
Korfhagen TR; Swantz RJ; Wert SE; McCarty JM; Kerlakian CB; Glasser SW; Whitsett JA
J Clin Invest; 1994 Apr; 93(4):1691-9. PubMed ID: 8163670
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of acute lung injury in transgenic mice expressing human transforming growth factor-alpha.
Hardie WD; Prows DR; Leikauf GD; Korfhagen TR
Am J Physiol; 1999 Nov; 277(5):L1045-50. PubMed ID: 10564191
[TBL] [Abstract][Full Text] [Related]
8. Perinatal increases in TGF-{alpha} disrupt the saccular phase of lung morphogenesis and cause remodeling: microarray analysis.
Kramer EL; Deutsch GH; Sartor MA; Hardie WD; Ikegami M; Korfhagen TR; Le Cras TD
Am J Physiol Lung Cell Mol Physiol; 2007 Aug; 293(2):L314-27. PubMed ID: 17468132
[TBL] [Abstract][Full Text] [Related]
9. Disrupted pulmonary vascular development and pulmonary hypertension in transgenic mice overexpressing transforming growth factor-alpha.
Le Cras TD; Hardie WD; Fagan K; Whitsett JA; Korfhagen TR
Am J Physiol Lung Cell Mol Physiol; 2003 Nov; 285(5):L1046-54. PubMed ID: 12896876
[TBL] [Abstract][Full Text] [Related]
10. Transient induction of TGF-alpha disrupts lung morphogenesis, causing pulmonary disease in adulthood.
Le Cras TD; Hardie WD; Deutsch GH; Albertine KH; Ikegami M; Whitsett JA; Korfhagen TR
Am J Physiol Lung Cell Mol Physiol; 2004 Oct; 287(4):L718-29. PubMed ID: 15090366
[TBL] [Abstract][Full Text] [Related]
11. Early growth response-1 suppresses epidermal growth factor receptor-mediated airway hyperresponsiveness and lung remodeling in mice.
Kramer EL; Mushaben EM; Pastura PA; Acciani TH; Deutsch GH; Khurana Hershey GK; Korfhagen TR; Hardie WD; Whitsett JA; Le Cras TD
Am J Respir Cell Mol Biol; 2009 Oct; 41(4):415-25. PubMed ID: 19188657
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary type II cell hypertrophy and pulmonary lipoproteinosis are features of chronic IL-13 exposure.
Homer RJ; Zheng T; Chupp G; He S; Zhu Z; Chen Q; Ma B; Hite RD; Gobran LI; Rooney SA; Elias JA
Am J Physiol Lung Cell Mol Physiol; 2002 Jul; 283(1):L52-9. PubMed ID: 12060560
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension.
Fujita M; Shannon JM; Irvin CG; Fagan KA; Cool C; Augustin A; Mason RJ
Am J Physiol Lung Cell Mol Physiol; 2001 Jan; 280(1):L39-49. PubMed ID: 11133493
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-alpha deficiency reduces pulmonary fibrosis in transgenic mice.
Madtes DK; Elston AL; Hackman RC; Dunn AR; Clark JG
Am J Respir Cell Mol Biol; 1999 May; 20(5):924-34. PubMed ID: 10226062
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor alpha (TGF(alpha)) is increased during hyperoxia and fibrosis.
Waheed S; D'Angio CT; Wagner CL; Madtes DK; Finkelstein JN; Paxhia A; Ryan RM
Exp Lung Res; 2002; 28(5):361-72. PubMed ID: 12097230
[TBL] [Abstract][Full Text] [Related]
16. Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor.
Hoyle GW; Li J; Finkelstein JB; Eisenberg T; Liu JY; Lasky JA; Athas G; Morris GF; Brody AR
Am J Pathol; 1999 Jun; 154(6):1763-75. PubMed ID: 10362801
[TBL] [Abstract][Full Text] [Related]
17. Genetic element from human surfactant protein SP-C gene confers bronchiolar-alveolar cell specificity in transgenic mice.
Glasser SW; Korfhagen TR; Wert SE; Bruno MD; McWilliams KM; Vorbroker DK; Whitsett JA
Am J Physiol; 1991 Oct; 261(4 Pt 1):L349-56. PubMed ID: 1928370
[TBL] [Abstract][Full Text] [Related]
18. Arrested lung morphogenesis in transgenic mice bearing an SP-C-TGF-beta 1 chimeric gene.
Zhou L; Dey CR; Wert SE; Whitsett JA
Dev Biol; 1996 May; 175(2):227-38. PubMed ID: 8626028
[TBL] [Abstract][Full Text] [Related]
19. GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice.
Huffman Reed JA; Rice WR; Zsengellér ZK; Wert SE; Dranoff G; Whitsett JA
Am J Physiol; 1997 Oct; 273(4):L715-25. PubMed ID: 9357845
[TBL] [Abstract][Full Text] [Related]
20. TGF-alpha perturbs surfactant homeostasis in vivo.
Ikegami M; Le Cras TD; Hardie WD; Stahlman MT; Whitsett JA; Korfhagen TR
Am J Physiol Lung Cell Mol Physiol; 2005 Jul; 289(1):L34-43. PubMed ID: 15764643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
